Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 3, 2019 Off

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Gilead Sciences

By BusinessWire

CHENGDU, China–(BUSINESS WIRE)–HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Gilead Sciences to…

June 3, 2019 Off

Alpine Immune Sciences Appoints Biopharma Veteran Wayne Gombotz as Chief Technology Officer

By BusinessWire

SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and…

June 3, 2019 Off

FSD Pharma Names Raza Bokhari, M.D. as Permanent CEO

By BusinessWire

Company Also Reports Q1 2019 Financial Results TORONTO–(BUSINESS WIRE)–#FSDDF–The Board of Directors of FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF)…

June 3, 2019 Off

Seattle Genetics and Astellas Announce Antibody-Drug Conjugate Enfortumab Vedotin Produced Tumor Response Rate of 44 Percent in Patients with Most Common Type of Advanced Urothelial (Bladder) Cancer

By BusinessWire

–First Investigational Therapy in a Pivotal Trial to Address Unmet Need for Patients with Advanced Urothelial Cancer After Treatment with…

June 3, 2019 Off

New Ad-hoc Analysis of Phase 3 HELP Study™ Evaluates Prevention of HAE Attacks with TAKHZYRO® (lanadelumab) During Early Treatment Phase

By BusinessWire

Data Presented at European Academy of Allergy and Clinical Immunology Congress OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today…

June 3, 2019 Off

Exicure to Present at LD Micro 9th Invitational Conference

By BusinessWire

CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#AANAM–Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…

June 3, 2019 Off

BIO International Convention Kicks Off in Philadelphia to Celebrate and Inspire the Future of Biotech

By BusinessWire

The world’s premier life sciences event returns to Philadelphia for four days of inspiring keynote speeches, fireside chats and educational…

June 3, 2019 Off

Findings from Can-Fite’s Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session

By BusinessWire

Phase III study protocol for Namodenoson in the treatment of advanced liver cancer patients is now being prepared and will…

June 3, 2019 Off

Ablexis Announces Multi-Target Licensing Agreement with Zai Lab (US)

By BusinessWire

Ablexis grants rights to use the AlivaMab™ Mouse platform for research, development and potential commercialization of antibodies SAN DIEGO–(BUSINESS WIRE)–Ablexis,…

June 3, 2019 Off

Bristol-Myers Squibb Announces First Presentation of Results for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combination in Advanced Hepatocellular Carcinoma at ASCO 2019

By BusinessWire

Opdivo plus Yervoy yielded objective response rate of 31% and median duration of response of 17.5 months Data demonstrate potential…

Posts pagination

Previous 1 … 3,141 3,142 3,143 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine